Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Head and Neck cancer (HNC) - Market Insight, Epidemiology And Market Forecast - 2032
... and neck cancer (HNC) historical and forecasted epidemiology as well as the Head and neck cancer (HNC) cancer market trends in the United States, EU-5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. ... Read More
-
Intratumoral Cancer Therapies - Market Insight, Epidemiology And Market Forecast - 2032
... forecasted epidemiology as well as the Intratumoral cancer therapies trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Intratumoral cancer therapies market report provides emerging drugs, Intratumoral cancer ... Read More
-
United States Liquid Biopsy Market, Size, Global Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Company Analysis
... the molecular examination of nucleic acids, subcellular structures, particularly exosomes, and, in the case of cancer, circulating tumor cells in bodily fluids. Liquid biopsy has been the subject of intense research over the last ten ... Read More
-
Oncolytic Virus Cancer Therapy - Market Insight, Epidemiology and Market Forecast – 2032
... Therapies (OVTs), historical and forecasted epidemiology as well as the Oncolytic Virus Therapies (OVTs) trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Oncolytic Virus Therapies (OVTs) market ... Read More
-
Hematological Cancer (Blood Cancer) Therapeutics- Market Insights, Competitive Landscape and, Market Forecast - 2027
... End-User (Hospital Pharmacies, Retail Pharmacy, And Others) and by geography is expected to grow at a steady CAGR forecast till 2027 owing to the increasing prevalence of blood cancer and increasing prevalence of lifestyle disorders ... Read More
-
mRNA Cancer Therapies Patent Landscape 2022
... such as mRNA technology leaders CureVac, Moderna and BioNTech. These optimizations were achieved by modifying RNA non-coding elements (5′ cap, 5′- and 3′- UTRs, 3′ poly-A tail) and RNA coding region, and through the development ... Read More
-
3D Cell Culture Market By Product (Scaffold Based Platforms, Scaffold Free Platforms, Gels, Bioreactors, Microchips, Services), By Application (Cancer Research, Stem Cell Research, Drug Discovery, Regenerative medicine), By End User (Biotechnology and Pharmaceutical Companies, Contract Research Laboratories, Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Research Laboratories, Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2021-2031 A 3D cell culture is an in-vitro technique wherein the cells can grow in an artificially created environment. These environments closely resemble the architecture ... Read More
-
Dermatology Imaging Devices Market Share, Size, Trends, Industry Analysis Report, By Imaging Modality (Digital Photographic Imaging, Dermoscopy); By Application (Pigmented Lesions, Psoriasis, Skin Cancer); By End-Use; By Region; Segment Forecast, 2022 - 2030
... dermatology imaging devices market size is expected to reach USD 3,183.88 million by 2030, according to a new study by Polaris Market Research. The report “Dermatology Imaging Devices Market Share, Size, Trends, Industry Analysis Report, ... Read More
-
Women Health Market Share, Size, Trends, Industry Analysis Report, By Type (Surgical, Contraceptive, Critical Care, Labor & Delivery, Diagnostic, Others), By Application; By Distribution Channel; By Region; Segment Forecast, 2022 - 2030
... Health Market size is expected to reach USD 58.10 billion by 2030, according to a new study by Polaris Market Research. The report “Women Health Market Share, Size, Trends, Industry Analysis Report, By Type (Surgical, ... Read More
-
Immuno-oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Type (Checkpoint Modulators, Cancer Vaccines) and End-User (Hospitals, Cancer Research Institute), 2022-2030
... and is expected to grow at a compound annual growth rate (CAGR) of 20.30% during 2022-2030. The immuno-oncology market report provides an executive-level overview of the immuno-oncology market worldwide today, with detailed forecasts of key ... Read More
-
Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs In Development, 2022, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape. Head and Neck Cancer is a cancer that arises in the head or neck region (in the nasal cavity, ... Read More
-
Oropharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Oropharyngeal Cancer (Oncology) pipeline landscape. Oropharyngeal cancer is a disease which malignant cells form in the tissue of oropharynx. Oropharynx is a middle part of the throat which includes the ... Read More
-
Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Fallopian Tube Cancer (Oncology) pipeline landscape. Fallopian tube cancer is also called tubal cancer. It develops in the fallopian tubes, which serve as a connection between the ovaries ... Read More
-
Basal Cell Carcinoma (Basal Cell Epithelioma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... (Basal Cell Epithelioma) - Drugs In Development, 2022, provides an overview of the Basal Cell Carcinoma (Basal Cell Epithelioma) (Oncology) pipeline landscape. Basal cell carcinoma is a type of skin cancer which begins in the ... Read More
-
Ureter Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Ureter Cancer (Oncology) pipeline landscape. Ureter cancer or ureteral cancer is cancer of the ureter. Symptoms and signs of urethral cancer include bleeding from the urethra or blood in the ... Read More
-
Hairy Cell Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Hairy Cell Leukemia (Oncology) pipeline landscape. Hairy cell leukemia is a rare, slow-growing cancer of the blood in which bone marrow makes too many B cells (lymphocytes), a ... Read More
-
Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Gastric Cancer (Oncology) pipeline landscape. Gastric cancer, also called stomach cancer, is a malignant tumor arising from the lining of the stomach. Signs and symptoms of gastric cancer include fatigue, ... Read More
-
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Cancer) - Drugs In Development, 2022, provides an overview of the Adrenocortical Carcinoma (Adrenal Cortex Cancer) (Oncology) pipeline landscape. Adrenal cortex cancer (ACC) is a rare disease. It is caused by a cancerous growth in ... Read More
-
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size study, By Drug (Monoclonal Antibodies, Immunomodulators, Cancer Vaccines and Oncolytic Therapies and Others }, Service (Target Identification and Validation, Lead screening and Characterization, Cell based Assays), By Cancer Type ( Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer and Pancreatic Cancer), and Regional Forecasts 2022-2028
... Cancer Type ( Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer and Pancreatic Cancer), and Regional Forecasts 2022-2028 Global Cancer Immunotherapy Drug Discovery Outsourcing Market is valued approximately ... Read More
-
Head and Neck Cancer Therapeutics: Global Markets
... to help businesses develop growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding head and neck cancer therapeutic drugs. An in-depth analysis of the global ... Read More
-
North America and South & Central America Medical Marijuana Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Dried Form and Extract Form), Application (Pain Management, Tourette’s, Alzheimer’s Disease, Migraines, Depression and Anxiety, Multiple Sclerosis, Cancer, and Others), Distribution Channel (Retail Pharmacy, E-Commerce, and Others), and Regions
... Anxiety, Multiple Sclerosis, Cancer, and Others), Distribution Channel (Retail Pharmacy, E-Commerce, and Others), and Regions The North America and South & Central America medical marijuana market was valued at US$ 6,645.16 million in 2021 and ... Read More
-
Pain Management Devices Market Analysis And Forecast To 2031: By Type (Electrical Stimulators, Radiofrequency Ablation (RFA), Analgesic Infusion Pumps, Neurostimulation), Length (Cancer, Neuropathic Pain, Facial & Migraine, Musculoskeletal Disorder, Trauma), And Region
... management devices market was valued at USD 2.2 billion in 2021 and it is anticipated to grow up to USD 8.0 billion by 2031, at a CAGR of 13.8% during the forecast period. Pain management ... Read More
-
Glycomic Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Class (Isolated and Synthetic), Structures [Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins & Heparin Based Glycans, Targeting Glycosphingolipids, and Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate; Erythropoietin & Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 & 3; Beta & Gamma Interferons; and Others]
... Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins ... Read More
-
NAMPT Inhibitors Market, 2022-2040
... by 2040, the number of cancer cases is projected to reach over 28 million, indicating a cumulative growth of nearly 47%, since 2020. The continuous growth in the number of cancer patients imposes a huge ... Read More
-
FLT3 Inhibitors Market - A Global and Country Analysis: Focus on Commercialized Therapy, Potential Pipeline Product, and Region - Analysis and Forecast, 2022-2032
... expected to reach $2,061.3 million in 2032 from $400.9 million in 2021 at a CAGR of 14.88% during the forecast period 2022-2032. The global FLT3 inhibitors market growth is expected to be driven by the ... Read More
Research Assistance
